Back to top
more

Patterson Companies (PDCO)

(Real Time Quote from BATS)

$21.40 USD

21.40
224,984

-0.53 (-2.42%)

Updated Sep 5, 2024 12:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Earnings Estimates Rising for Patterson Cos. (PDCO): Will It Gain?

by Zacks Equity Research

Patterson Cos. (PDCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Patterson Companies (PDCO) Catches Eye: Stock Jumps 5.9%

by Zacks Equity Research

Patterson Companies (PDCO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y

by Zacks Equity Research

Patterson Companies' (PDCO) fiscal third-quarter results benefit from higher revenues and solid show by Dental as well as Animal Health segments.

Patterson Cos. (PDCO) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 27.03% and 2.75%, respectively, for the quarter ended January 2020. Do the numbers hold clues to what lies ahead for the stock?

STERIS' (STE) Growth Picture Impressive Amid Rising Costs

by Zacks Equity Research

STERIS (STE) growing steadily on favorable underlying market trends, along with new product and service offerings.

What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

by Zacks Equity Research

Patterson Companies (PDCO) expects Animal Health sales to have been soft in fiscal Q3.

Abbott's Alliance With Insulet to Fortify Diabetic Care Unit

by Zacks Equity Research

Both Abbott (ABT) and Insulet will use a pay-as-you-go model to enhance customer acceptance.

Integra LifeSciences Grows Organically Amid Supply Issues

by Zacks Equity Research

Integra LifeSciences' (IART) Codman Specialty Surgical segment registers impressive organic growth in Q4.

Integer Holdings Acquires Inomec, Extends Global Foothold

by Zacks Equity Research

Integer Holdings' (ITGR) Inomec buyout is likely to boost R&D pipeline and also strengthen and expand global foothold.

HealthEquity (HQY) Stock Up on Solid Fiscal 2020 Results

by Zacks Equity Research

HealthEquity (HQY) raises fiscal 2020 view for top and bottom line.

Baxter's Latest Acquisition to Boost Advanced Surgery Arm

by Zacks Equity Research

Baxter's (BAX) Advanced Surgery arm boasts of a wide spectrum of products.

Here's Why You Should Hold on to Cerner (CERN) Stock Now

by Zacks Equity Research

Cerner (CERN) is gaining traction from prudent strategic deals and big data based EHR system. However, weak margins remain a woe.

Here's Why You Should Invest in Cardinal Health Stock Now

by Zacks Equity Research

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment.

Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

by Zacks Equity Research

DaVita (DVA) gains from solid results in the fourth quarter of 2019.

Sreyoshi Mukherjee headshot

Bleak Outlook for Medical Dental Supplies Industry

by Sreyoshi Mukherjee

Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.

PDCO vs. WST: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. WST: Which Stock Is the Better Value Option?

Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (PDCO) Outperforming Other Medical Stocks This Year?

Can Value Investors Consider Patterson Companies (PDCO)?

by Zacks Equity Research

Patterson Companies (PDCO) stock may be a good choice for value-oriented investors right now from multiple angles.

Moving Average Crossover Alert: Patterson Companies

by Zacks Equity Research

Patterson Companies, Inc. (PDCO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Masimo Posts Solid Preliminary 2019 Results, Issues Guidance

by Zacks Equity Research

Higher revenues and upbeat 2020 outlook benefit Masimo's (MASI) preliminary full-year 2019 results.

Should Value Investors Buy Patterson Cos. (PDCO) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Baxter Posts Upbeat Q4 Preliminary Results, Issues Guidance

by Zacks Equity Research

Higher revenues, growth in all geographic segments and six business units benefit Baxter's (BAX) Q4 preliminary operating results.

Here's Why You Should Hold on to Cardinal Health Stock Now

by Zacks Equity Research

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

PDCO or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PDCO vs. WST: Which Stock Is the Better Value Option?